EV Biologics, Inc. (YECO)

EV Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 12, 2024	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Market Capitalization	1	7	6	21	71	-
Market Cap Growth	-76.71%	6.81%	-70.36%	-71.13%	-	-
Enterprise Value	17	17	-14	0	68	-
Last Close Price	0.14	2.70	2.54	8.57	30.00	-
PE Ratio	-	-	-	-	8.21	-
PS Ratio	0.04	0.69	0.64	0.48	1.54	-
PB Ratio	0.01	0.15	1.64	1.83	1.53	-
P/TBV Ratio	0.16	0.16	3.69	2.26	1.71	-
P/FCF Ratio	-	-	-	-	17.02	-
P/OCF Ratio	-	-	3.93	1.55	11.49	-
EV/Sales Ratio	1.75	1.75	-	0.01	1.47	-
EV/EBITDA Ratio	-	-	-	0.09	4.66	-
EV/EBIT Ratio	106.82	106.82	-	0.16	5.29	-
EV/FCF Ratio	-	-	-	-	16.26	-
Debt / Equity Ratio	0.15	0.15	3.19	1.04	0.33	0.52
Debt / EBITDA Ratio	-	-	-	2.17	1.05	1.17
Debt / FCF Ratio	-	-	-	-	3.66	1.72
Asset Turnover	-	-	0.27	0.75	0.63	0.70
Inventory Turnover	-	-	26.51	71.77	74.69	74.71
Quick Ratio	0.80	0.80	0.23	0.34	0.84	1.83
Current Ratio	3.11	3.11	0.30	0.42	0.87	1.96
Return on Equity (ROE)	-	-	-99.17%	-183.68%	20.59%	33.15%
Return on Assets (ROA)	-	-	-7.05%	3.49%	10.92%	15.02%
Return on Capital (ROIC)	-	-	-12.74%	4.69%	13.50%	18.50%
Earnings Yield	-160.64%	-8.47%	-121.90%	-258.71%	12.19%	-
FCF Yield	-	-6.22%	-113.55%	5.88%	-
Buyback Yield / Dilution	-0.68%	-	-1.02%	-49.09%	-	-
Total Shareholder Return	-0.68%	-	-1.02%	-49.09%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.